Keywords
Uganda
Categories
How to Cite
Abstract
Objective: To describe the clinical presentation, management, and treatment outcomes of Mooren’s ulcer
in Uganda.
Methods: We reviewed records of all patients diagnosed with Mooren’s ulcer at Ruharo Eye Centre
from January 2013 to December 2015. We collected data from fifty-two patient charts on demographic
characteristics, history and presenting complaints, eye affected, clinical presentation, modes of medical
and surgical treatment, and post treatment visual acuity.
Results: The median age was 24.5 years (IQR 16.5 years). The ratio of males to females was 8:1. Thirty two
(82.1%) patients presented with pain, 13 (33.3%) with redness, and 10 (25.7%) with tearing. Forty seven
(90.4%) patients had unilateral disease. Four (80%) of those with bilateral disease were aged 30 years and
above while one (20%) was below 30 years. Twenty nine (55.8%) of the patients received only medical
treatment and 23 (44.2%) received various forms of surgical management. Forty one (78.8%) still had
active ulceration on their last review date, 7 (13.5%) perforated after admission, 3 (5.8%) of the patients
were marked as healed on their last review date, and one (1.92%) was eviscerated. At the last follow up,
most patients ended with worse visual acuity (n=21, 40.4%) while 20 (38.5%) had no change and only 11
(21.2%) improved.
Conclusion: This primary study provided background information on presentation of Mooren’s ulcer in
Uganda; our data indicated that younger males were the most affected group; severe disease occurred in
older patients.
References
Chen J, Xie H, Wang Z, Yang B, Liu Z, Chen L,
et al. Mooren’s ulcer in China: a study of clinical
characteristics and treatment. Br J Ophthalmol.
; 84(11):1244-1249.
Foster CS, Kenyon KR, Greiner J. The
immunopathology of Mooren’s ulcer. Amer J
Ophthalmol. 1979; 88 (2): 149-159.
Schallenberg M, Westekemper H, Steuhl K,
Meller D. Amniotic membrane transplantation
ineffective as additional therapy in patients with
aggressive Mooren’s ulcer. BMC Ophthalmol.
; 13(81):1471-2415.
Taylor C, Smith S, Morgan C, Stephenson S,
Key T, Srinivasan M, et al. HLA and Mooren’s
ulceration. Br J Ophthalmol. 2000; 84(1): 72-75.
Sangwan VS, Zafirakis P, Foster C. Mooren’s
ulcer: Current concepts in management. Curr
Ophthalmol. 1997; 45(1):7-17.
Hwang FS, Sirajeldin A. Mooren’s Ulcer.
American Academy of Ophthalmology; 2015
[updated 04/08/2015; cited 2016 25/01/2016];
Available from: http://eyewiki.aao.org/Mooren’s_Ulcer.
Sangwan VS, Zafirakis P, Foster CS. Mooren’s
ulcer: Current concepts in management. Indian J
Ophthalmol. 1997; 45 (1): 7-17.
Abah ER, Akinwande AO, Pam VA. Mooren’s
corneal ulceration in a pseudophakic eye: A case
report and literature review. Annals Nigerian Med.
; 6(1): 50.
Al Motowa S, Al Zobidi M. Amniotic membrane
transplant with a special technique (Motowa’s
Sandwich Technique) in Mooren’s ulcer. Middle
East Afr J Ophthalmol. 2015; 22(3): 386-388.
Fasina O, Ogundipe A, Ezichi E. Mooren’S ulcer
in ibadan, southwest Nigeria. J West Afr Coll Surg.
; 3(3): 102-119.
Lewallen S, Courtright P. Problems with current
concepts of the epidemiology of Mooren’s corneal
ulcer: Annals Ophthalmol. 1990; 22(2) 52-55. 62.
Bhandari V, Siddharthan KS. Bilateral Mooren’s
ulcer - Customised corneal graft with additional
amniotic membrane graft. Saudi J Ophthalmol.
; 29(3): 235-237.
Kietzman B. Mooren’s ulcer in Nigeria. Amer J
Ophthalmol. 1968; 65(5): 679-685.
Srinivasan M, Zegans ME, Zelefsky JR,
Kundu A, Lietman T, Whitcher JP, et al. Clinical
characteristics of Mooren’s ulcer in South
India. [Editorial]: Br J Ophthalmol. 2007;
(5): 570-575.